Suzanne Sirois

1.3k total citations
23 papers, 1.1k citations indexed

About

Suzanne Sirois is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Suzanne Sirois has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Computational Theory and Mathematics and 6 papers in Organic Chemistry. Recurrent topics in Suzanne Sirois's work include Computational Drug Discovery Methods (9 papers), Advanced Chemical Physics Studies (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Suzanne Sirois is often cited by papers focused on Computational Drug Discovery Methods (9 papers), Advanced Chemical Physics Studies (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Suzanne Sirois collaborates with scholars based in Canada, China and United States. Suzanne Sirois's co-authors include Dong‐Qing Wei, Dennis R. Salahub, Kuo‐Chen Chou, Qi-Shi Du, Emil Proynov, René Roy, Dzung T. Nguyen, Qi‐Shi Du, Mohamed Touaibia and Kuo‐Chen Chou and has published in prestigious journals such as The Journal of Chemical Physics, Analytical Biochemistry and Journal of Bacteriology.

In The Last Decade

Suzanne Sirois

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Sirois Canada 18 586 255 252 245 141 23 1.1k
Ricardo Bicca de Alencastro Brazil 21 555 0.9× 262 1.0× 473 1.9× 124 0.5× 162 1.1× 115 1.6k
Shinji Amari Japan 12 422 0.7× 199 0.8× 81 0.3× 245 1.0× 146 1.0× 16 913
Jayashree Srinivasan United States 11 1.7k 3.0× 380 1.5× 225 0.9× 180 0.7× 147 1.0× 16 2.2k
Koushi Hidaka Japan 26 913 1.6× 502 2.0× 333 1.3× 124 0.5× 72 0.5× 74 1.8k
Guy H. Grant United Kingdom 21 696 1.2× 101 0.4× 213 0.8× 122 0.5× 124 0.9× 53 1.3k
Vladimı́r Frecer Slovakia 22 813 1.4× 238 0.9× 335 1.3× 73 0.3× 74 0.5× 86 1.4k
Ànna Pavlova United States 20 756 1.3× 149 0.6× 107 0.4× 169 0.7× 195 1.4× 44 1.4k
Aravindhan Ganesan Canada 15 433 0.7× 217 0.9× 205 0.8× 72 0.3× 66 0.5× 41 930
V. Mohan United States 21 1.2k 2.1× 269 1.1× 237 0.9× 110 0.4× 120 0.9× 38 1.5k
Yongping Pan United States 23 820 1.4× 140 0.5× 146 0.6× 91 0.4× 82 0.6× 34 1.2k

Countries citing papers authored by Suzanne Sirois

Since Specialization
Citations

This map shows the geographic impact of Suzanne Sirois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Sirois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Sirois more than expected).

Fields of papers citing papers by Suzanne Sirois

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Sirois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Sirois. The network helps show where Suzanne Sirois may publish in the future.

Co-authorship network of co-authors of Suzanne Sirois

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Sirois. A scholar is included among the top collaborators of Suzanne Sirois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Sirois. Suzanne Sirois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sirois, Suzanne & L. Martin Cloutier. (2008). Needed: system dynamics for the drug discovery process. Drug Discovery Today. 13(15-16). 708–715. 6 indexed citations
2.
Cloutier, L. Martin & Suzanne Sirois. (2008). Bayesian versus Frequentist statistical modeling: A debate for hit selection from HTS campaigns. Drug Discovery Today. 13(11-12). 536–542. 7 indexed citations
3.
Touaibia, Mohamed, A. Wellens, Tze Chieh Shiao, et al.. (2007). Mannosylated G(0) Dendrimers with Nanomolar Affinities to Escherichia coli FimH. ChemMedChem. 2(8). 1190–1201. 148 indexed citations
4.
Sirois, Suzanne, Mohamed Touaibia, Kuo‐Chen Chou, & René Roy. (2007). Glycosylation of HIV-1 gp120 V3 Loop: Towards the Rational Design of a Synthetic Carbohydrate Vaccine. Current Medicinal Chemistry. 14(30). 3232–3242. 27 indexed citations
5.
Sirois, Suzanne, Denis Giguère, & René Roy. (2006). A First QSAR Model for Galectin-3 Glycomimetic Inhibitors Based on 3D Docked Structures. Medicinal Chemistry. 2(5). 481–489. 19 indexed citations
6.
Giguère, Denis, Sachiko Sato, C. St-Pierre, Suzanne Sirois, & René Roy. (2006). Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3: Role of electrostatic potential at O-3. Bioorganic & Medicinal Chemistry Letters. 16(6). 1668–1672. 56 indexed citations
7.
Du, Qi‐Shi, et al.. (2006). Anti-SARS drug screening by molecular docking. Amino Acids. 31(1). 73–80. 50 indexed citations
8.
Chou, Kuo‐Chen, et al.. (2006). Progress in Computational Approach to Drug Development Against SARS. Current Medicinal Chemistry. 13(27). 3263–3270. 91 indexed citations
9.
Sirois, Suzanne, Tobias Sing, & Kuo‐Chen Chou. (2005). HIV-1 gp120 V3 Loop for Structure-Based Drug Design. Current Protein and Peptide Science. 6(5). 413–422. 45 indexed citations
10.
Sirois, Suzanne, George Hatzakis, Dong‐Qing Wei, Qi-Shi Du, & Kuo‐Chen Chou. (2005). Assessment of chemical libraries for their druggability. Computational Biology and Chemistry. 29(1). 55–67. 52 indexed citations
11.
Sirois, Suzanne, et al.. (2005). Selection of Molecular Descriptors with Artificial Intelligence for the Understanding of HIV-1 Protease Peptidomimetic Inhibitors-activity. Medicinal Chemistry. 1(2). 173–184. 11 indexed citations
12.
13.
Du, Qi‐Shi, et al.. (2004). Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide. Peptides. 25(11). 1857–1864. 69 indexed citations
14.
Sirois, Suzanne, Dong‐Qing Wei, Qi-Shi Du, & Kuo‐Chen Chou. (2004). Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore Points. Journal of Chemical Information and Computer Sciences. 44(3). 1111–1122. 108 indexed citations
15.
Sirois, Suzanne, Emil Proynov, Jean‐François Truchon, Chris Tsoukas, & D. R. Salahub. (2003). A density functional study of the hydrogen‐bond network within the HIV‐1 protease catalytic site cleft. Journal of Computational Chemistry. 24(9). 1110–1119. 8 indexed citations
16.
Wei, Dong‐Qing, Jean‐François Truchon, Suzanne Sirois, & Dennis R. Salahub. (2002). Solvation of formic acid and proton transfer in hydrated clusters. The Journal of Chemical Physics. 116(14). 6028–6038. 53 indexed citations
17.
Nguyen, Dzung T., Andrew C. Scheiner, Jan Andzelm, et al.. (1997). A density functional study of the glycine molecule: Comparison with post-Hartree-Fock calculations and experiment. Journal of Computational Chemistry. 18(13). 1609–1631. 73 indexed citations
18.
Sirois, Suzanne & George Szatmari. (1995). Detection of XerC and XerD recombinases in gram-negative bacteria of the family Enterobacteriaceae. Journal of Bacteriology. 177(14). 4183–4186. 20 indexed citations
19.
Sirois, Suzanne, Miguel Castro, & Dennis R. Salahub. (1994). A density functional study of the interaction of CO2 with a Pd atom. International Journal of Quantum Chemistry. 52(S28). 645–654. 22 indexed citations
20.
Rodriquez, Christopher F., Suzanne Sirois, & Alan C. Hopkinson. (1992). Effect of multiple halide substituents on the acidity of methanes and methyl radicals. Electron affinities of chloro- and fluoromethyl radicals. The Journal of Organic Chemistry. 57(18). 4869–4876. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026